ScholarIQanswers from OpenAlex

Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk

PaperCitations, authors & open-access status

Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk have?

ScholarIQcitation count

Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk has 355 citations in the OpenAlex counts ScholarIQ stores.

When was Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk published?

ScholarIQyear

Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk has 2004 year in the ScholarIQ index.

What is the open-access status of Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk?

ScholarIQoa status

Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk has green oa status in the ScholarIQ index.

What is the DOI of Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk?

ScholarIQdoi

The DOI for Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk is on the source record.

What is the PMID of Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk?

ScholarIQpmid

The PMID for Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk is on the source record.

What is the OpenAlex record for Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk?

ScholarIQopenalex

The OpenAlex for Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial